BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis.
2015 ◽
Vol 33
(15_suppl)
◽
pp. e14605-e14605
Keyword(s):
2016 ◽
Vol 37
(2)
◽
pp. 155-165
◽
Keyword(s):
2000 ◽
Vol 82
(11)
◽
pp. 1789-1794
◽
2015 ◽
Vol 112
(12)
◽
pp. 1888-1894
◽
2010 ◽
Vol 38
(4)
◽
pp. 2219-2223
◽
Keyword(s):
2014 ◽
Vol 29
(4)
◽
pp. 197-203
◽
2015 ◽
Vol 113
(11)
◽
pp. 1635-1635
◽
2009 ◽
Vol 10
(4)
◽
pp. 247-257
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 3597-3597
◽
2013 ◽
Vol 139
(5)
◽
pp. 891-900
◽